Mix-Med, Testosterone Mix, 225 mg/ml, 10 ml

This synergistic multi-component injectable formulation by Bioniche Pharma integrates three complementary short-ester androgenic compounds: Trenbolone Acetate, Drostanolone Propionate, and Testosterone Propionate. Engineered by Bioniche Pharma to maximize anabolic response, drive cellular nitrogen retention, and encourage tissue repair, this fast-acting combination accelerates skeletal muscle recovery and counters hypercatabolic states when combined with proper nutritional intake.

CLINICAL PHARMACOLOGY & MECHANISM OF ACTION

The active agents in this triple-blend formulation by Bioniche Pharma act concurrently by binding with high affinity to intracellular androgen receptors, stimulating protein translation and inhibiting catabolic glucocorticoid activity. Administration supports male physiological functions, including lean tissue accretion and structural protein synthesis. Systemically, Bioniche Pharma's multi-component blend encourages renal conservation of nitrogen, sodium, potassium, and phosphorus while reducing calcium excretion, fostering a strongly positive metabolic balance.

INDICATIONS & CLINICAL USE

• Targeted therapeutic stimulation of protein anabolism, cellular repair, and tissue preservation in malnourished, debilitated, or hypercatabolic patients using Bioniche Pharma preparations.
• Adjunctive clinical management of severe muscle atrophy, cachexia, and involuntary weight loss associated with chronic wasting conditions under medical supervision.

CONTRAINDICATIONS

• Male patients with diagnosed or suspected prostate carcinoma or male breast cancer.
• Female breast carcinoma complicated by severe hypercalcemia (elevated serum calcium levels).
• Patients presenting with severe renal disease, advanced kidney failure, or major hepatic impairment.
• Pregnancy and lactation due to high risks of fetal virilization, structural developmental abnormalities, and profound endocrine disruption.
• Known hypersensitivity or allergic reaction to Trenbolone Acetate, Drostanolone Propionate, Testosterone Propionate, carrier oils, or inactive components in Bioniche Pharma formulations.

PRECAUTIONS & METABOLIC MONITORS

• Glycemic Control: Exogenous anabolic-androgenic agents can alter peripheral insulin sensitivity and glucose clearance. Diabetic patients receiving Bioniche Pharma products should perform routine blood glucose monitoring, as anti-diabetic medication dosages may require adjustment.
• Pediatric Caution & Skeletal Growth: Contraindicated in children and adolescents under 18 years of age due to risks of premature epiphyseal plate closure, compromised adult stature, and precocious sexual development.
• Cardiovascular & Hepatic Surveillance: Routine monitoring of liver transaminase activity, blood pressure, serum lipid profiles (elevated LDL and reduced HDL), and hematocrit levels is required during Bioniche Pharma therapy.

ADVERSE REACTIONS

• Endocrine & Reproductive: Suppression of the endogenous pituitary-gonadal axis, reduced sperm production, testicular suppression, priapism (persistent or painful erections), and potential progestational or estrogenic effects associated with Bioniche Pharma multi-component therapy.
• Dermatological & Androgenic: Heightened sebum production, severe acne vulgaris, accelerated male pattern baldness (androgenetic alopecia), and alterations in body hair growth patterns.
• Gastrointestinal, CNS & Respiratory: Gastrointestinal distress, mood changes, heightened anxiety, sleep disturbances, headaches, dyspnea, and sodium retention leading to peripheral edema.

DOSAGE & ADMINISTRATION

This triple-component blend by Bioniche Pharma is formulated exclusively for deep intramuscular injection. Given the rapid clearance rates of the short acetate and propionate esters, consistent administration scheduling is necessary to prevent hormone fluctuations:

• Therapeutic Schedule: Administration is typically performed 2 to 3 times per week, yielding a cumulative weekly dosage range of 450 mg to 675 mg (2 ml to 3 ml total weekly volume) as customized by a qualified physician.
• Restriction: Strictly contraindicated for female patients, pediatric populations, and adolescents.

STORAGE & HANDLING

Store Bioniche Pharma injectable products in a cool, dry place shielded from direct light, elevated temperatures, and freezing conditions. Keep strictly out of the reach and sight of children.